Bill > S3087

This bill aims to combat the distribution and use of counterfeit fentanyl and methamphetamine substances by expanding legal definitions and enforcement strategies. The bill first defines "counterfeit fentanyl or methamphetamine substance" as any substance containing these drugs that is marketed or sold under a false trademark or identifying mark. It amends the Controlled Substances Act to include fentanyl and its analogues in existing prohibitions against methamphetamine-related criminal activities. The bill requires the Drug Enforcement Administration (DEA) to develop a comprehensive plan within 180 days, which includes strategies for federal law enforcement to investigate and seize these substances, increase education and prevention efforts (particularly targeting youth), and audit existing public awareness campaigns like "One Pill Can Kill". Additionally, the bill mandates an annual report to Congress from the Attorney General, in consultation with the DEA and Office of National Drug Control Policy, detailing data on seized substances, the types of illicit substances found in counterfeit pills, geographical seizure information, charges filed, convictions, sentences, and ongoing prevention measures. The overall goal is to address the growing threat of dangerous counterfeit substances that can cause overdoses and deaths.

Justice

https://www.congress.gov/bill/119th-congress/senate-bill/3087/all-info